1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019
Date - Oct 01, 2019
Product - Zirabev (biosimilar, bevacizumab)
The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept 2019,…
The third quarter of 2019 has ended with major acquisitions in the pharma and biotech industry along with multiple approvals. Starting with the latest acquisition where Biocon Biologics acquires Pfizer's Research Facility for expansion of its R&D footprints with the acceleration of the development of its biosimilars from lab to pilot scale. Previously, Amgen acquired…
Shots:
Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to come. PharmaShots has published 1,238 news and articles till date
We are grateful to all our subscribers for their affection towards PharmaShots and for subscribing our news alerts. We ensure to put…
The second quarter of 2019 has ended with major acquisitions in pharma and biotech industry. Moving with the latest acquisition of Allergan for $63B by AbbVie focusing on to generate revenue with addition of Allergan's medical aesthetics and ophthalmology portfolio. Prior to that, Pfizer acquired Array Biopharma for $11.4B to expand its oncology portfolio. Some…
Shots:
Team PharmaShots proudly announce that we are awarded as Top 50 Pharma Blog by Feedspot
We are thankful to Feedspot for identifying our efforts and awarding us with this honor. We will continue to put our effort to provide the latest news available to our subscribers
PharmaShots is a Digital News Media and Insights company that…

